Evaluation of barium and gastrografin as contrast media for the diagnosis of esophageal ruptures or perforations.
D000042:Absorption; D000818:Animals; D000891:Anti-Infective Agents, Local; D001466:Barium Sulfate / Q000633:toxicity; D002415:Cats; D003973:Diatrizoate / Q000633:toxicity; D004195:Disease Models, Animal; D004341:Drug Evaluation; D004939:Esophageal Perforation / Q000000981:diagnostic imaging*; D005122:Exudates and Transudates; D005337:Fibrin; D006099:Granuloma / Q000139:chemically induced; D006644:Histiocytes; D007422:Intestines / Q000382:microbiology; D008214:Lymphocytes; D008480:Mediastinitis / Q000150:complications / Q000209:etiology / Q000473:pathology; D009055:Mouth / Q000382:microbiology; D010950:Plasma Cells; D011859:Radiography
D000891:Anti-Infective Agents, Local; D003973:Diatrizoate; D001466:Barium Sulfate; D005337:Fibrin